Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01935089
Recruitment Status : Active, not recruiting
First Posted : September 4, 2013
Last Update Posted : November 2, 2016
University of Pennsylvania
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Luis Montaner, The Wistar Institute

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : July 2017
  Estimated Study Completion Date : July 2017